Association between symptoms, affect and heart rhythm in patients with persistent or paroxysmal atrial fibrillation: an ambulatory pilot study - 29/09/21
Doi : 10.1016/j.ahj.2021.06.003
Kevin M Wheelock, MD a, Anna Kratz, PhD c, Sangeeta Lathkar-Pradhan, MBBS c, Kayvan Najarian, PhD d, Jonathan Gryak, PhD d, Zhi Li, PhD d, Hakan Oral, MD b, Daniel J. Clauw, MD e, Brahmajee K. Nallamothu, MD, MP c, Hamid Ghanbari, MD, MPH c, ⁎ 
a Department of Internal Medicine, Yale School of Medicine
b Department of Physical Medicine and Rehabilitation, University of Michigan Medical School
c Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical School
d Department of Emergency Medicine, University of Michigan Medical School
e Department of Internal Medicine, Division of Rheumatology, University of Michigan Medical School
⁎Reprint requests: Hamid Ghanbari, MD, MPH, Department of Internal Medicine, Division of Cardiovascular Medicine, Cardiac Electrophysiology Services, 1500 East Medical Center Drive, Ann Arbor, Michigan. 48109-5853.Department of Internal Medicine, Division of Cardiovascular Medicine, Cardiac Electrophysiology Services1500 East Medical Center DriveAnn Arbor48109-5853Michigan
Abstract |
Symptoms in atrial fibrillation are generally assumed to correspond to heart rhythm; however, patient affect – the experience of feelings, emotion or mood – is known to frequently modulate how patients report symptoms but this has not been studied in atrial fibrillation. In this study, we investigated the relationship between affect, symptoms and heart rhythm in patients with paroxysmal or persistent atrial fibrillation. We found that presence of negative affect portended reporting of more severe symptoms to the same or greater extent than heart rhythm.
Le texte complet de cet article est disponible en PDF.Plan
© 2021
Elsevier Inc. Tous droits réservés.
Vol 241
P. 1-5 - novembre 2021 Retour au numéro
Article précédent
- The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial
- Felix Böhm, Brynjölfur Mogensen, Ollie Östlund, Thomas Engstrøm, Eigil Fossum, Goran Stankovic, Oskar Angerås, Andrejs ?rglis, Madhav Menon, Carl Schultz, Colin Berry, Christoph Liebetrau, Mika Laine, Claes Held, Andreas Rück, Stefan K. James
- Nationwide cardiovascular disease admission rates during a second COVID-19 lockdown
- Daniel Mølager Christensen, Jawad Haider Butt, Emil Fosbøl, Lars Køber, Christian Torp-Pedersen, Gunnar Gislason, Matthew Phelps
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?